<p>IMR-32 cells were exposed to different doses (1, 5, 10 ng/ml) of protectin (19,20-DiHDPA, 10(S),17(S)-DiHDoHE) and incubated for 24 hrs. At the end of treatment period, cell viability was measured by MTT assay. All values are expressed as mean ± standard error (n = 6). *P<0.05 when compared to control.</p
<p>BRL-4 cells (A) and MCF-7 cells (B) were treated with increasing doses of simvastatin for 24, 48 ...
Cells were grown in the presence of PLA surfaces for two days after which their protein content was ...
<p>Cells were treated with 2.5, 5, 10, 20 and 40 µM ABT-737 for 24 h before and the cell viabilities...
<p>IMR-32 cells were exposed to different doses (10, 50, 100 ng/ml) of prostaglandins (PGE1, PGE2, P...
<p>(A) Effect of pre-treatment with different doses (1, 5, 10 ng/ml) of protectin (19,20-DiHDPA, 10(...
<p>IMR-32 cells were exposed to different doses (1, 5, 10 ng/ml) of resolvin (D1, D2) and incubated ...
<p>IMR-32 cells were exposed to different doses (10, 50, 100 ng/ml) of leukotrienes (D4, E4) and inc...
<p>IMR-32 cells were exposed to different doses (1, 5, 10 ng/ml) of lipoxin A4 and incubated for 24 ...
MCF-7 cells were plated at a density of 1.5x104 cells per well in 96-well plates and grown for 24 h....
<p>MDA-MB 231 cells were transfected with siRNA-LAMR1 and cell viability was determined with the MTT...
<p>U937 cell were exposed to 10 µg/mL of LPS for 24 h and cell viability was assessed by MTT assay. ...
<p>After the treatments and incubation, alterations in cell viability were measured by the MTT assay...
<p>THP-1 human monocytes were plated and treated with OmpU or protein-buffer or PmB and incubated fo...
<p>Cells were treated with various compounds for 4h, and grown for another 20h. (A)IC50 of HeLa and ...
<p>Survival percentages of SHSY5Y cells incubated with 30 µM Aβs for 72 hours. Wells containing SHSY...
<p>BRL-4 cells (A) and MCF-7 cells (B) were treated with increasing doses of simvastatin for 24, 48 ...
Cells were grown in the presence of PLA surfaces for two days after which their protein content was ...
<p>Cells were treated with 2.5, 5, 10, 20 and 40 µM ABT-737 for 24 h before and the cell viabilities...
<p>IMR-32 cells were exposed to different doses (10, 50, 100 ng/ml) of prostaglandins (PGE1, PGE2, P...
<p>(A) Effect of pre-treatment with different doses (1, 5, 10 ng/ml) of protectin (19,20-DiHDPA, 10(...
<p>IMR-32 cells were exposed to different doses (1, 5, 10 ng/ml) of resolvin (D1, D2) and incubated ...
<p>IMR-32 cells were exposed to different doses (10, 50, 100 ng/ml) of leukotrienes (D4, E4) and inc...
<p>IMR-32 cells were exposed to different doses (1, 5, 10 ng/ml) of lipoxin A4 and incubated for 24 ...
MCF-7 cells were plated at a density of 1.5x104 cells per well in 96-well plates and grown for 24 h....
<p>MDA-MB 231 cells were transfected with siRNA-LAMR1 and cell viability was determined with the MTT...
<p>U937 cell were exposed to 10 µg/mL of LPS for 24 h and cell viability was assessed by MTT assay. ...
<p>After the treatments and incubation, alterations in cell viability were measured by the MTT assay...
<p>THP-1 human monocytes were plated and treated with OmpU or protein-buffer or PmB and incubated fo...
<p>Cells were treated with various compounds for 4h, and grown for another 20h. (A)IC50 of HeLa and ...
<p>Survival percentages of SHSY5Y cells incubated with 30 µM Aβs for 72 hours. Wells containing SHSY...
<p>BRL-4 cells (A) and MCF-7 cells (B) were treated with increasing doses of simvastatin for 24, 48 ...
Cells were grown in the presence of PLA surfaces for two days after which their protein content was ...
<p>Cells were treated with 2.5, 5, 10, 20 and 40 µM ABT-737 for 24 h before and the cell viabilities...